Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David Chang
AddedFeb 13, 2024
UpdatedJun 28, 2026
David Chang

David Chang

Co-Founder, Start Tank

CrunchbaseLinkedInThe Org

David Chang's Career

Start Tank
Start Tank

Boston, MA, US

Co-Founder
Allogene Therapeutics
Allogene Therapeutics

South San Francisco, CA, US

Founder
CO Everywhere
CO Everywhere

Boston, MA, US

Board Member· Board
Peloton Therapeutics
Peloton Therapeutics

Dallas, TX, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David Chang's Career

Start Tank
Start Tank
Investment FirmInvestment Firm502012Boston, MA, US
Co-Founder

Leadership at Start Tank

David DelmarDavid DelmarCo-Founder

Similar to Start Tank

Startup HavenStartup HavenSeattle, WA, USest. 2006Startup HavenSeattle, WA, US · est. 2006

Venture-scale startup community for founders, executives, and investors.

Investment Firm39
RockstartRockstartAmsterdam, North Holland, NLest. 2011RockstartAmsterdam, North Holland, NL · est. 2011

Rockstart: A full-service startup accelerator providing capital, market access, community, and expertise.

Investment Firm281
StartaStartaNew York City, NY, USest. 2011StartaNew York City, NY, US · est. 2011

Starta: A tech startup ecosystem fostering and funding early-stage talent for global scaling.

Investment Firm30
Founders ClubFounders ClubLos Altos, CA, USest. 2010Founders ClubLos Altos, CA, US · est. 2010

Venture capital firm offering a startup community for co-founders, investors, and mentors.

Investment Firm30
Allogene Therapeutics
Allogene Therapeutics
Public$781.8M3612017South San Francisco, CA, US
Founder

Leadership at Allogene Therapeutics

Liz BarrettLiz BarrettBoard Member
Stephen L. MayoStephen L. MayoBoard Member
Debbie MessemerDebbie MessemerBoard Member
Owen WitteOwen WitteBoard Member
John DeYoungJohn DeYoungBoard Member
Franz HumerFranz HumerBoard Member
CO Everywhere
CO Everywhere
Series A$17.5M2752013Boston, MA, US
Board Member· Board

Recent news

How startups could be affected by a prolonged government shutdownTechCrunch · 2025
Executive assistants, high salaries, and other ways early-stage founders will trigger a seed VCTechCrunch · 2024

Leadership at CO Everywhere

Dan AdamsDan AdamsFounder
Anthony LongoAnthony LongoCEO
Peloton Therapeutics
Peloton Therapeutics
Acquired$242.6M02010Dallas, TX, US
Board Member· Board

Leadership at Peloton Therapeutics

John CreecyJohn CreecyBoard Member
Michael S. BrownMichael S. BrownCo-Founder
Tim KutzkeyTim KutzkeyBoard Member
David GoeddelDavid GoeddelBoard Member
Steven McKnightSteven McKnightCo-Founder
Helen S KimHelen S KimBoard Member

Similar to Peloton Therapeutics

Pelican TherapeuticsPelican TherapeuticsBoca Raton, FL, USBiologic Agentsest. 2009Pelican TherapeuticsBoca Raton, FL, US · est. 2009

Pelican Therapeutics: Advancing next-gen TNF-based immunotherapy in biotechnology.

Series B · $15.6M4
Palm TherapeuticsPalm TherapeuticsSan Diego, CA, USCancer Treatmentest. 2018Palm TherapeuticsSan Diego, CA, US · est. 2018

Revolutionizing cancer treatment with next-gen root-level therapeutics.

Angel · $991.1k7
PanTher TherapeuticsPanTher TherapeuticsWatertown, MA, USCancer Treatmentest. 2016PanTher TherapeuticsWatertown, MA, US · est. 2016

PanTher Therapeutics: Revolutionizing cancer care with an effective, minimal side-effect treatment platform.

Series B · $21.3M13
G1 TherapeuticsG1 TherapeuticsTriangle (historical), NC, USCancer Therapiesest. 2008G1 TherapeuticsTriangle (historical), NC, US · est. 2008

US-based G1 Therapeutics develops innovative treatments for oncology and breast cancer.

Public · $697.4M170

David Chang's Co-Investors

Michael WinterMichael WinterCo-invested · Patented.ai Pre-SeedJeff FagnanJeff FagnanCo-invested · Patented.ai Pre-SeedNeil SirniNeil SirniCo-invested · Patented.ai Pre-SeedWilliam KoffelWilliam KoffelCo-invested · Patented.ai Pre-SeedNaval RavikantNaval RavikantCo-invested · Patented.ai Pre-SeedJonathan CorbinJonathan CorbinCo-invested · Patented.ai Pre-SeedPhilip H. BeauregardPhilip H. BeauregardCo-invested · Patented.ai Pre-SeedVikas MohindraVikas MohindraCo-invested · Patented.ai Pre-Seed

David Chang's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakHaeil YiHaeil YiCo-Founder · DunamuLee Sirg-OoLee Sirg-OoCEO · Dunamu

People Similar to David Chang

Lawrence BlattLawrence BlattBoard Member · Aligos TherapeuticsGeoffrey ParkerGeoffrey ParkerBoard Member · Better TherapeuticsEric T. SchmidtEric T. SchmidtBoard Member · Relmada TherapeuticsChun-Hao HuangChun-Hao HuangCo-Founder · Algen BiotechnologiesFrank BorrielloFrank BorrielloFounder · Alloplex BiotherapeuticsStephen MayfieldStephen MayfieldFounder & CEO · Algenesis